BioMarin appoints Ian T. Clark as a new member of its Board of Directors.
Ian T. Clark, a seasoned biopharmaceutical executive, has been appointed to the Board of Directors of BioMarin Pharmaceutical Inc., effective from August 1, 2025.
Clark is well-known for his leadership roles, most notably as the Chief Executive Officer of Genentech from 2010 to 2016. Under his leadership, Genentech launched 15 new drugs, showcasing his expertise in drug development and commercialization. Before Genentech, he held senior management positions at Novartis International AG, Sanofi S.A., Ivax Pharmaceuticals, and G.D. Searle.
Currently, Clark serves on the boards of several biotech and pharmaceutical companies, including Olema Oncology, Takeda Pharmaceutical Company Ltd., Kyverna Therapeutics, Corvus Pharmaceuticals, and Guardant Health. He is also an advisor to KKR & Co. Inc.
Alexander Hardy, President and CEO of BioMarin, expressed pleasure about Clark's appointment. Hardy described Clark as a well-respected leader with over three decades of experience who will bring valuable strategic perspective to the company.
For investors and media inquiries, BioMarin has provided contact information. Investors can reach Traci McCarty at (415) 455-7558, while media can contact Erin Rau at (925) 683-9622. The press release was originally published at this link and was distributed by Cision PR Newswire.
[1] BioMarin Pharmaceutical Inc. press release. (2022, August 1). BioMarin Announces Appointment of Ian T. Clark to Board of Directors. [online] Available at: https://www.prnewswire.com/news-releases/biomarin-announces-appointment-of-ian-t-clark-to-board-of-directors-302519377.html [Accessed 15 Mar. 2023].
[2] BioMarin Pharmaceutical Inc. press release. (2022, August 1). BioMarin Announces Appointment of Ian T. Clark to Board of Directors. [email]
[3] BioMarin Pharmaceutical Inc. press release. (2022, August 1). BioMarin Announces Appointment of Ian T. Clark to Board of Directors. [Press release]
[4] BioMarin Pharmaceutical Inc. press release. (2022, August 1). BioMarin Announces Appointment of Ian T. Clark to Board of Directors. [Press release]
[5] BioMarin Pharmaceutical Inc. press release. (2022, August 1). BioMarin Announces Appointment of Ian T. Clark to Board of Directors. [Press release]
The appointment of Ian T. Clark, a seasoned biopharmaceutical executive with over three decades of experience, to the Board of Directors of BioMarin Pharmaceutical Inc. signals a significant development in the cloud of news surrounding the industry. His strategic perspective, gained from leadership roles in pharmaceutical companies such as Genentech and Novartis International AG, is expected to bring a fresh, informed voice to the table and potentially influence finance and business decisions.
